China Pharma Holdings Inc. (CPHI)
NYSE · Healthcare
China Pharma Holdings Inc. Total Liabilities 2010–2025
China Pharma Holdings Inc. annual total liabilities history from 2010 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- China Pharma Holdings Inc. total liabilities as of December 31, 2025: 8.3M, a 15.69% increase year-over-year.
- China Pharma Holdings Inc. total liabilities for 2025 were 8.3M, a 15.69% increase from 2024.
- China Pharma Holdings Inc. total liabilities for 2024 were 7.1M, a 20.80% decrease from 2023.
- China Pharma Holdings Inc. total liabilities for 2023 were 9.0M, a 33.20% decrease from 2022.
- China Pharma Holdings Inc. total liabilities for 2022 were 13.5M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| China Pharma Holdings Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $8 |
| 2024 | $7 |
| 2023 | $9 |
| 2022 | $13 |
| 2021 | $17 |
| 2020 | $13 |
| 2019 | $13 |
| 2018 | $15 |
| 2017 | $17 |
| 2016 | $20 |
| 2015 | $24 |
| 2014 | $28 |
| 2013 | $25 |
| 2012 | $15 |
| 2011 | $14 |
China Pharma Holdings Inc. Total Liabilities — FAQ
China Pharma Holdings Inc. (CPHI) total liabilities over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CPHI's total liabilities history?
The chart and table above show China Pharma Holdings Inc.'s total liabilities by year and by quarter, including the growth rate.